BioXcel Therapeutics, Inc. (BTAIQ): Capital Expenditures
$0
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0 | n/a | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $0 | -100.0% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $20.0K | -85.6% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $139.0K | -68.8% | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | $445.0K | +40.8% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $316.0K | -63.7% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $870.0K | +155.9% | 2021-03-12, From 2019-01-01 |
| 2018-12-31 | $340.0K | n/a | 2020-03-09, From 2018-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $0 | n/a |
| Polomar Health Services, Inc. (PMHS) | 2024-12-31 | $90.9K | n/a |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $22.0K | -67.2% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $442.3K | n/m |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $24.6K | -42.7% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $0 | -100.0% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $55.0K | -73.9% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $1.2K | -98.8% |
| Hyperion Defi, Inc. (HYPD) | 2024-12-31 | $161.5K | -94.3% |
Compare BTAIQ, PMHS, VCNX, ELAB side by side · Screen every company in Pharmaceutical Preparations ↗